"ProAssurance Specialty Insurance Company","PNC AS","2024 03 31" Annual Statutory Statement

STATEMENT AS OF MARCH 31, 2024 OF THE ProAssurance Specialty Insurance Company

ASSETS

		Current Statement Date		4
	1	2	3	December 31

			Net Admitted Assets	Prior Year Net
	Assets	Nonadmitted Assets	(Cols. 1 - 2)	Admitted Assets
1. Bonds	183,900,795		183,900,795	197,240,963

2. Stocks:

2.1 Preferred stocks

2.2 Common stocks

1,655,275

1,774,980

Mortgage loans on real estate:
1. First liens
2. Other than first liens
Real estate:
1. Properties occupied by the company (less

	$		encumbrances)
	4.2 Properties held for the production of income
	(less $		encumbrances)
	4.3 Properties held for sale (less
	$		encumbrances)
5.	Cash ($	(1,441,763) ),
	cash equivalents ($		17,572,016	)
	and short-term investments ($	1,082,065 )	17,212,318	17,212,318	2,180,214
6.	Contract loans (including $		premium notes)

Derivatives
Other invested assets
Receivables for securities
Securities lending reinvested collateral assets
Aggregate write-ins for invested assets

12.	Subtotals, cash and invested assets (Lines 1 to 11)	202,768,388		202,768,388	201,196,157
13.	Title plants less $	charged off (for Title insurers
	only)
14.	Investment income due and accrued		956,957		956,957	1,057,024
15.	Premiums and considerations:
	15.1 Uncollected premiums and agents' balances in the course of
	collection		1,301,827	748,371	553,456	4,909,590
	15.2 Deferred premiums, agents' balances and installments booked but
	deferred and not yet due (including $		earned
	but unbilled premiums)		14,637,863		14,637,863	9,218,126
	15.3 Accrued retrospective premiums	($	) and
	contracts subject to redetermination ($	)
16.	Reinsurance:
	16.1 Amounts recoverable from reinsurers	19,769,676		19,769,676	21,003,995

Funds held by or deposited with reinsured companies
Other amounts receivable under reinsurance contracts

17. Amounts receivable relating to uninsured plans

18.1 Current federal and foreign income tax recoverable and interest thereon
18.2 Net deferred tax asset		3,443,738	930,805	2,512,933	3,880,070
19.	Guaranty funds receivable or on deposit
20.	Electronic data processing equipment and software
21.	Furniture and equipment, including health care delivery assets
	($	)
22.	Net adjustment in assets and liabilities due to foreign exchange rates
23.	Receivables from parent, subsidiaries and affiliates	2,942,910		2,942,910	7,884,143
24.	Health care ($	) and other amounts receivable
25.	Aggregate write-ins for other-than-invested assets	846,874	827,103	19,771
26.	Total assets excluding Separate Accounts, Segregated Accounts and
	Protected Cell Accounts (Lines 12 to 25)	246,668,233	2,506,279	244,161,954	249,149,105
27.	From Separate Accounts, Segregated Accounts and Protected
	Cell Accounts
28.	Total (Lines 26 and 27)		246,668,233	2,506,279	244,161,954	249,149,105
	DETAILS OF WRITE-INS
1101.
1102.
1103.
1198.	Summary of remaining write-ins for Line 11 from overflow page
1199.	Totals (Lines 1101 through 1103 plus 1198) (Line 11 above)
2501.	Deductible Receivable		827,103	827,103
2502.	State Income Tax Recoverable	19,771		19,771
2503.
2598.	Summary of remaining write-ins for Line 25 from overflow page
2599.	Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)	846,874	827,103	19,771

STATEMENT AS OF MARCH 31, 2024 OF THE ProAssurance Specialty Insurance Company

LIABILITIES, SURPLUS AND OTHER FUNDS

				1	2
				Current	December 31,
				Statement Date	Prior Year
1.	Losses (current accident year $	3,776,500 )		31,789,055	36,397,906
2.	Reinsurance payable on paid losses and loss adjustment expenses
3.	Loss adjustment expenses			36,400,409	31,282,792
4.	Commissions payable, contingent commissions and other similar charges
5.	Other expenses (excluding taxes, licenses and fees)		2,357,867	3,157,920
6.	Taxes, licenses and fees (excluding federal and foreign income taxes)		25,227	86,457
7.1Current federal and foreign income taxes (including $	on realized capital gains (losses))	4,420,460	4,905,046
7.2 Net deferred tax liability
8.	Borrowed money $	and interest thereon $
9.	Unearned premiums (after deducting unearned premiums for ceded reinsurance of $	59,144,247 and
	including warranty reserves of $	and accrued accident and health experience rating refunds
	including $	for medical loss ratio rebate per the Public Health Service Act)	12,531,636	13,329,603
10.	Advance premium			512,011	4,141,779

11. Dividends declared and unpaid:

Stockholders
Policyholders

12.	Ceded reinsurance premiums payable (net of ceding commissions)	29,452,108	30,704,967
13.	Funds held by company under reinsurance treaties		15,000,000	15,000,000
14.	Amounts withheld or retained by company for account of others		597,632	704,293
15.	Remittances and items not allocated
16.	Provision for reinsurance (including $	certified)	194,000	194,000

Net adjustments in assets and liabilities due to foreign exchange rates
Drafts outstanding

19.	Payable to parent, subsidiaries and affiliates	1,224,911	313,412
20.	Derivatives
21.	Payable for securities	749,678

Payable for securities lending
Liability for amounts held under uninsured plans

24.	Capital notes $	and interest thereon $
25.	Aggregate write-ins for liabilities		2,827,785	5,188,465
26.	Total liabilities excluding protected cell liabilities (Lines 1 through 25)	138,082,779	145,406,640
27.	Protected cell liabilities
28.	Total liabilities (Lines 26 and 27)		138,082,779	145,406,640
29.	Aggregate write-ins for special surplus funds
30.	Common capital stock		3,600,000	3,600,000

Preferred capital stock
Aggregate write-ins for other than special surplus funds
Surplus notes

34.	Gross paid in and contributed surplus		56,486,447	56,486,447
35.	Unassigned funds (surplus)			45,992,728	43,656,018
36.	Less treasury stock, at cost:
	36.1	shares common (value included in Line 30	$	)
	36.2	shares preferred (value included in Line 31	$	)
37.	Surplus as regards policyholders (Lines 29 to 35, less 36)			106,079,175	103,742,465
38.	Totals (Page 2, Line 28, Col. 3)		244,161,954	249,149,105
	DETAILS OF WRITE-INS
2501.	Unearned Fee Income					25,000
2502.	Retroactive insurance reserve assumed		6,782,012	2,787,128
2503.	Retroactive insurance reserve ceded		(6,782,012)	(2,787,128)
2598.	Summary of remaining write-ins for Line 25 from overflow page		2,827,785	5,163,465
2599.	Totals (Lines 2501 through 2503 plus 2598) (Line 25 above)		2,827,785	5,188,465
2901.
2902.
2903.
2998.	Summary of remaining write-ins for Line 29 from overflow page
2999.	Totals (Lines 2901 through 2903 plus 2998) (Line 29 above)
3201.
3202.
3203.
3298.	Summary of remaining write-ins for Line 32 from overflow page
3299.	Totals (Lines 3201 through 3203 plus 3298) (Line 32 above)

STATEMENT AS OF MARCH 31, 2024 OF THE ProAssurance Specialty Insurance Company

STATEMENT OF INCOME

						1	2	3
						Current Year	Prior Year	Prior Year Ended
						to Date	to Date	December 31
1.	Premiums earned:	UNDERWRITING INCOME

	1.1	Direct (written $	44,107,331	)		38,099,227	29,081,966	137,655,694
	1.2	Assumed (written $		)			540,593	(408,996)
	1.3	Ceded (written $	38,714,044	)		31,907,972	23,694,154	112,852,010
	1.4	Net (written $	5,393,287	)		6,191,255	5,928,405	24,394,688
2.		DEDUCTIONS:
Losses incurred (current accident year $	4,141,900 ):
	2.1 Direct				13,907,495	18,601,901	98,775,575
	2.2 Assumed					340,574	(488,667)
	2.3 Ceded				15,800,216	16,512,335	96,215,063
3.	2.4 Net				(1,892,721)	2,430,140	2,071,845
Loss adjustment expenses incurred			7,810,095	3,083,048	1,089,058
4.	Other underwriting expenses incurred			584,426	(1,641,703)	4,667,223
5.	Aggregate write-ins for underwriting deductions
6.	Total underwriting deductions (Lines 2 through 5)		6,501,800	3,871,485	7,828,126
7.	Net income of protected cells
8.	Net underwriting gain (loss) (Line 1 minus Line 6 + Line 7)		(310,545)	2,056,920	16,566,562
9.	Net investment income earned	INVESTMENT INCOME		1,259,750	1,183,582	5,260,047

10.	Net realized capital gains (losses) less capital gains tax of $	(147,422)	(554,589)
11.	Net investment gain (loss) (Lines 9 + 10)			705,161	1,183,582	5,260,047
12.			OTHER INCOME
Net gain or (loss) from agents' or premium balances charged off
13.	(amount recovered $		amount charged off $	9,662 )	(9,662)	(8,291)	(38,198)
Finance and service charges not included in premiums
14.	Aggregate write-ins for miscellaneous income		227,612	108,680	460,478
15.	Total other income (Lines 12 through 14)			217,950	100,389	422,280
16.	Net income before dividends to policyholders, after capital gains tax and before all other federal
	and foreign income taxes (Lines 8 + 11 + 15)		612,566	3,340,891	22,248,889

Dividends to policyholders
Net income, after dividends to policyholders, after capital gains tax and before all other federal

19.	and foreign income taxes (Line 16 minus Line 17)	612,566	3,340,891	22,248,889
Federal and foreign income taxes incurred	(337,164)	147,260	4,909,197
20.	Net income (Line 18 minus Line 19)(to Line 22)	949,730	3,193,631	17,339,692
21.	CAPITAL AND SURPLUS ACCOUNT
Surplus as regards policyholders, December 31 prior year	103,742,467	86,939,527	86,939,527
22.	Net income (from Line 20)	949,730	3,193,631	17,339,692

Net transfers (to) from Protected Cell accounts
Change in net unrealized capital gains or (losses) less capital gains tax of

25.	$	104,838	274,685	542,701	(13,881)
Change in net unrealized foreign exchange capital gain (loss)
26.	Change in net deferred income tax	(1,476,333)	(1,128,547)	1,979,116
27.	Change in nonadmitted assets	2,588,626	605,205	(2,527,987)
28.	Change in provision for reinsurance			26,000

Change in surplus notes
Surplus (contributed to) withdrawn from protected cells
Cumulative effect of changes in accounting principles
Capital changes:
1. Paid in
2. Transferred from surplus (Stock Dividend)
3. Transferred to surplus
Surplus adjustments:
1. Paid in
2. Transferred to capital (Stock Dividend)
3. Transferred from capital
Net remittances from or (to) Home Office
Dividends to stockholders
Change in treasury stock
Aggregate write-ins for gains and losses in surplus

38.	Change in surplus as regards policyholders (Lines 22 through 37)	2,336,708	3,212,990	16,802,940
39.	Surplus as regards policyholders, as of statement date (Lines 21 plus 38)	106,079,175	90,152,517	103,742,467
0501.	DETAILS OF WRITE-INS

0502.
0503.
0598.	Summary of remaining write-ins for Line 5 from overflow page
0599.	TOTALS (Lines 0501 through 0503 plus 0598) (Line 5 above)
1401.	Fee income	25,000	89,375	328,125
1402.	Miscellaneous Income	202,612	19,305	132,353
1403.
1498.	Summary of remaining write-ins for Line 14 from overflow page
1499.	TOTALS (Lines 1401 through 1403 plus 1498) (Line 14 above)	227,612	108,680	460,478
3701.
3702.
3703.
3798.	Summary of remaining write-ins for Line 37 from overflow page
3799.	TOTALS (Lines 3701 through 3703 plus 3798) (Line 37 above)

STATEMENT AS OF MARCH 31, 2024 OF THE ProAssurance Specialty Insurance Company

CASH FLOW

				1	2	3
				Current Year	Prior Year	Prior Year Ended
				To Date	To Date	December 31
1.		Cash from Operations
Premiums collected net of reinsurance		(642,893)	(1,041,741)	30,351,798
2.	Net investment income		1,629,719	1,515,499	5,881,940
3.	Miscellaneous income		217,950	100,389	422,280
4.	Total (Lines 1 to 3)		1,204,776	574,147	36,656,018
5.	Benefit and loss related payments		4,177,085	1,064,125	23,938,234
6.	Net transfers to Separate Accounts, Segregated Accounts and Protected Cell Accounts
7.	Commissions, expenses paid and aggregate write-ins for deductions		(4,387,252)	(4,534,147)	19,916,191
8.	Dividends paid to policyholders
9.	Federal and foreign income taxes paid (recovered) net of $	tax on capital
10.	gains (losses)				(108,286)
Total (Lines 5 through 9)		(210,167)	(3,470,022)	43,746,139
11.	Net cash from operations (Line 4 minus Line 10)		1,414,943	4,044,169	(7,090,121)
12.		Cash from Investments
Proceeds from investments sold, matured or repaid:
	12.1	Bonds		20,687,073	5,580,805	20,091,579
	12.2	Stocks
	12.3	Mortgage loans
	12.4	Real estate
	12.5	Other invested assets
	12.6	Net gains or (losses) on cash, cash equivalents and short-term investments
	12.7	Miscellaneous proceeds			2,650,000	2,650,000
13.	12.8	Total investment proceeds (Lines 12.1 to 12.7)		20,687,073	8,230,805	22,741,579
Cost of investments acquired (long-term only):
	13.1	Bonds		7,819,590	352,956	16,782,152
	13.2	Stocks				2,524,960
	13.3	Mortgage loans
	13.4	Real estate
	13.5	Other invested assets
	13.6	Miscellaneous applications		(749,678)
14.	13.7	Total investments acquired (Lines 13.1 to 13.6)		7,069,912	352,956	19,307,112
Net increase/(decrease) in contract loans and premium notes
15.	Net cash from investments (Line 12.8 minus Line 13.7 and Line 14)		13,617,161	7,877,849	3,434,467
16.		Cash from Financing and Miscellaneous Sources
Cash provided (applied):
	16.1	Surplus notes, capital notes
	16.2	Capital and paid in surplus, less treasury stock
	16.3	Borrowed funds
	16.4	Net deposits on deposit-type contracts and other insurance liabilities
	16.5	Dividends to stockholders
	16.6	Other cash provided (applied)
17.	Net cash from financing and miscellaneous sources (Line 16.1 through Line 16.4 minus Line 16.5
	plus Line 16.6)
18.		RECONCILIATION OF CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS
Net change in cash, cash equivalents and short-term investments (Line 11, plus Lines 15 and 17)	15,032,104	11,922,018	(3,655,654)
19.	Cash, cash equivalents and short-term investments:
	19.1	Beginning of year		2,180,214	5,835,868	5,835,868
	19.2	End of period (Line 18 plus Line 19.1)		17,212,318	17,757,886	2,180,214

6WDWHPHQWDVRI0DUFKRIWKH352$6685$1&(63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

Note 1 - Summary of Significant Accounting Policies and Going Concern

Accounting practices
The financial statements of ProAssurance Specialty Insurance Company (the Company) are presented on the basis of accounting practices prescribed or permitted by the Vermont Department of Financial Regulation (the Department).
The Department recognizes only statutory accounting practices (SAP) prescribed or permitted by the State of Vermont for determining and reporting the financial condition and results of operations of an insurance company and for determining its solvency under the Vermont insurance law. The National Association of Insurance
Commissioners' (NAIC) Accounting Practices and Procedures Manual has been adopted as a component of prescribed or permitted practices by the State of Vermont.
Although the Vermont Commissioner of Insurance has the right to permit other specific practices that deviate from prescribed practices, no prescribed or permitted practices were used in the preparation of the accompanying financial statements.

						Year-to-date period ended
NET INCOME	SSAP	F/S	F/S		March 31,	December 31,
#	Page	Line #		2024		2023
(1)	State basis (Page 4, Line 20, Columns 1 & 3)	XXX	XXX	XXX	$	949,730	$	17,339,689
(2)	State Prescribed Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(3)	State Permitted Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(4)	NAIC SAP (1-2-3=4)	XXX	XXX	XXX	$	949,730	$	17,339,689
SURPLUS
(5)	State basis (Page 3, Line 37, Columns 1 & 2)	XXX	XXX	XXX	$	106,079,175	$	103,742,465
(6)	State Prescribed Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(7)	State Permitted Practices that are an increase/					-		-
(decrease) from NAIC SAP:
(8)	NAIC SAP (5-6-7=8)	XXX	XXX	XXX	$	106,079,175	$	103,742,465

The term "none" or "no significant change" is used in the following notes to indicate that the Company does not have any items requiring disclosure under the respective note.

Use of estimates in the preparation of the financial statements - No significant change.
Accounting policy
1. - (5) No significant change.

1. Loan-backedsecurities are reported at amortized cost provided that the SVO's designation is 1 or 2. If the SVO's designation is 3 or greater, the security is reported at the lower of amortized cost or fair value. The Company uses the prospective method to make valuation adjustments when necessary.
2. - (13) No significant change.
Going Concern
Management has concluded that there is no doubt regarding the Company's ability to continue as a going concern.

Note 2 - Accounting Changes and Corrections of Errors- None.

Note 3 - Business Combinations and Goodwill- None.

Note 4 - Discontinued Operations- None.

6WDWHPHQWDVRI0DUFKRIWKH352$6685$1&(63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

Note 5 - Investments

Mortgage loans, including mezzanine real estate loans - None.
Debt restructuring - None.
Reverse mortgages - None.
Loan-backedsecurities
1. Prepayment assumptions for single-class and multi-classmortgage-backed/asset-backed securities were obtained from broker dealer survey values or internal estimates.
2. The Company has recognized no other-than-temporary impairments of loan-backed securities for intent to sell or for inability to hold to recovery as of March 31, 2024.
3. No loan-backed securities, held as of March 31, 2024, have incurred other-than-temporary impairments recognized in earnings based on the fact that the present value of projected cash flows expected to be collected was less than the amortized cost of the securities.
4. For all loan-backed securities held at March 31, 2024 for which fair value is less than cost, but which have had no other-than-temporary impairment recognized in earnings, the following table displays balances, according to duration of the loss position:
5. 1. The aggregate amount of unrealized losses:

1.	Less than 12 Months	$	(37,274)
2.	12 Months or Longer	$	(6,794,159)
b. The aggregate related fair value of securities with unrealized losses:
1.	Less than 12 Months	$	6,241,535
2.	12 Months or Longer	$	37,116,327

1. The Company used pricing services in determining the fair value of its loan-backed securities. In determining that a security is not other-than-temporarily impaired, securities are analyzed for future cash flows by using current and expected losses, historical and expected prepayment speeds (based on Bloomberg and broker dealer survey values), and assumptions about recoveries relative to the seniority or subordination in the capital structure. If the results indicate that the Company will be able to maintain the current book yield, no other-than-temporary impairment is warranted.
Dollar repurchase agreements and/or securities lending transactions - None.
Repurchase agreements transactions accounted for as secured borrowing - None.
Reverse repurchase agreements transactions accounted for as secured borrowing - None.
Repurchase agreements transactions accounted for as a sale - None.
Reverse repurchase agreements transactions accounted for as a sale - None.
Real estate - None.
Low-incomehousing tax credits (LIHTC) - None.
Restricted assets - No significant change.
Working capital finance investments - None.
Offsetting and netting of assets and liabilities - None.
5GI Securities - None.
Short sales - None.
Prepayment penalty and acceleration fees - No significant change.

Note 6 - Joint Ventures, Partnerships and Limited Liability Companies

Detail for those greater than 10% of admitted assets - None.
Write-downsfor impairments - None.

6.1

6WDWHPHQWDVRI0DUFKRIWKH352$6685$1&(63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

Note 7 - Investment Income

Accrued investment income - None.
Amounts nonadmitted - None.
The gross nonadmitted and admitted amounts for interest income due and accrued.

Interest Income Due and Accrued		Amount
1.	Gross	$	956,957
2.	Nonadmitted	$	-
3.	Admitted	$	956,957

The aggregate deferred interest - None.
The cumulative amounts of paid-in-kind (PIK) interest included in the current principal balance - None.

Note 8 - Derivative Instruments- None.

Note 9 - Income Taxes
A. The components of the net deferred tax asset/(liability) at December 31 are as follows:
1.
				3/31/2024
			(1)		(2)		(3)
							(Col 1+2)
			Ordinary		Capital		Total
(a)	Gross Deferred Tax Assets	$	3,605,687	$	520,568	$	4,126,255
(b)	Statutory Valuation Allowance Adjustments		-		520,568		520,568
(c)	Adjusted Gross Deferred Tax Assets (1a - 1b)		3,605,687		-		3,605,687
(d)	Deferred Tax Assets Nonadmitted		930,805		-		930,805
(e)	Subtotal Net Admitted Deferred Tax Asset (1c - 1d)		2,674,882		-		2,674,882
(f)	Deferred Tax Liabilities		161,949		-		161,949
(g)	Net Admitted Deferred Tax Asset/(Net Deferred Tax	$	2,512,933	$	-	$	2,512,933
	Liability)(1e-1f)

				12/31/2023
			(4)		(5)		(6)
							(Col 4+5)
			Ordinary		Capital		Total
(a)	Gross Deferred Tax Assets	$	4,685,448	$	625,406	$	5,310,854
(b)	Statutory Valuation Allowance Adjustments		-		132,891		132,891
(c)	Adjusted Gross Deferred Tax Assets (1a - 1b)		4,685,448		492,515		5,177,963
(d)	Deferred Tax Assets Nonadmitted		652,324		492,515		1,144,839
(e)	Subtotal Net Admitted Deferred Tax Asset (1c - 1d)		4,033,124		-		4,033,124
(f)	Deferred Tax Liabilities		153,054		-		153,054
(g)	Net Admitted Deferred Tax Asset/(Net Deferred Tax	$	3,880,070	$	-	$	3,880,070
	Liability)(1e-1f)

					Change
			(7)		(8)		(9)
							(Col 7+8)
			Ordinary		Capital		Total
(a)	Gross Deferred Tax Assets	$	(1,079,761)	$	(104,838)	$	(1,184,599)
(b)	Statutory Valuation Allowance Adjustments		-		387,677		387,677
(c)	Adjusted Gross Deferred Tax Assets (1a - 1b)		(1,079,761)		(492,515)		(1,572,276)
(d)	Deferred Tax Assets Nonadmitted		278,481		(492,515)		(214,034)
(e)	Subtotal Net Admitted Deferred Tax Asset (1c - 1d)		(1,358,242)		-		(1,358,242)
(f)	Deferred Tax Liabilities		8,895		-		8,895
(g)	Net Admitted Deferred Tax Asset/(Net Deferred Tax	$	(1,367,137)	$	-	$	(1,367,137)
	Liability)(1e-1f)

6.2

6WDWHPHQWDVRI0DUFKRIWKH352$6685$1&(63(&,$/7<,1685$1&(&203$1<

127(672),1$1&,$/67$7(0(176

2.				3/31/2024
		(1)		(2)		(3)
						(Col 1+2)
Admission Calculation Components SSAP No. 101		Ordinary		Capital		Total
(a) Federal Income Taxes Paid in Prior Years Recoverable	$	307,860	$	-	$	307,860
Through Loss Carrybacks
(b) Adjusted Gross Deferred Tax Assets Expected To Be Realized	$	2,205,070	$	-	$	2,205,070
(Lesser of 2(b)1 and 2(b)2 Below)
1. Adjusted Gross Deferred Tax Assets Expected To Be	$	2,205,070	$	-	$	2,205,070
Realized Following the Balance Sheet Date
2. Adjusted Gross Deferred Tax Assets Allowed per		XXX		XXX	$	15,548,565
Limitation Threshold
(c) Adjusted Gross Deferred Tax Assets Offset by Gross Deferred	$	161,952	$	-	$	161,952
Tax Liabilities
(d) Deferred Tax Assets Admitted as the result of application of	$	2,674,882	$	-	$	2,674,882
SSAP No. 101

			12/31/2023
		(4)		(5)		(6)
						(Col 4+5)
		Ordinary		Capital		Total
(a) Federal Income Taxes Paid in Prior Years Recoverable	$	307,860	$	-	$	307,860
Through Loss Carrybacks
(b) Adjusted Gross Deferred Tax Assets Expected To Be Realized	$	3,561,271	$	-	$	3,561,271
(Lesser of 2(b)1 and 2(b)2 Below)
1. Adjusted Gross Deferred Tax Assets Expected To Be	$	3,561,271	$	-	$	3,561,271
Realized Following the Balance Sheet Date
2. Adjusted Gross Deferred Tax Assets Allowed per		XXX		XXX	$	14,975,459
Limitation Threshold
(c) Adjusted Gross Deferred Tax Assets Offset by Gross Deferred	$	163,993	$	-	$	163,993
Tax Liabilities
(d) Deferred Tax Assets Admitted as the result of application of	$	4,033,124	$	-	$	4,033,124
SSAP No. 101

				Change
		(7)		(8)		(9)
		(Col 1-4)		(Col 2-5)		(Col 7+8)
		Ordinary		Capital		Total

Federal Income Taxes Paid in Prior Years Recoverable Through Loss Carrybacks
Adjusted Gross Deferred Tax Assets Expected To Be Realized (Lesser of 2(b)1 and 2(b)2 Below)
1. Adjusted Gross Deferred Tax Assets Expected To Be Realized Following the Balance Sheet Date
2. Adjusted Gross Deferred Tax Assets Allowed per Limitation Threshold
Adjusted Gross Deferred Tax Assets Offset by Gross Deferred Tax Liabilities
Deferred Tax Assets Admitted as the result of application of SSAP No. 101

Ratio Percentage Used To Determine Recovery Period And Threshold Limitation Amount
Amount Of Adjusted Capital And Surplus Used To Determine Recovery Period And Threshold Limitation in 2(b)2 Above

$	- $	- $		-
$ (1,356,201)	$	-	$	(1,356,201)
$ (1,356,201)	$	-	$	(1,356,201)
	XXX		XXX	$	573,106
$	(2,041)	$	-	$	(2,041)
$ (1,358,242)	$	-	$	(1,358,242)

	3/31/2024		12/31/2023
	1,145 %	1,103 %
$ 103,657,098		$ 99,836,395

6.3

Attachments

Disclaimer

ProAssurance Corporation published this content on 03 June 2024 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 June 2024 20:02:45 UTC.

"ProAssurance Specialty Insurance Company","PNC AS","2024 03 31" Annual Statutory Statement

Advisor News

Annuity News

Health/Employee Benefits News

Life Insurance News

"ProAssurance Specialty Insurance Company","PNC AS","2024 03 31" Annual Statutory Statement

Advisor News

Annuity News

Health/Employee Benefits News

Life Insurance News

Sign in with your Insider Pro Account